Author: Chandana Thota
AI Boosts Organoid Research with Quality Prediction
Researchers from Kyushu University and Nagoya University have harnessed artificial intelligence (AI) to revolutionize organoid.
Colibactin-Producing E. coli Linked to Cancer Risk
Recent research highlights a potential connection between specific E. coli strains and increased cancer rates.
WHO Grants Prequalification to Xpert MTB/RIF Ultra
The World Health Organization (WHO) has granted prequalification to the Xpert MTB/RIF Ultra, a molecular.
FDA Approves BIZENGRI® for NRG1+ Cancer Therapy
The FDA has approved BIZENGRI® (zenocutuzumab-zbco), the first therapy specifically targeting neuregulin 1 (NRG1) gene.
US Census Data Reveals Air Pollution & Cancer Risk
A recent study from Desert Research Institute (DRI) and the University of Nevada, Reno, provides.
Broken Sleep: A Warning Sign of Liver Disease
A recent study found a surprising link between liver disease, specifically metabolic dysfunction-associated steatotic liver.
Improving Cancer Care in South Asia
A recent series of studies published in The Lancet Oncology sheds light on the pressing.
Safe Anti-Seizure Medications for Pregnancy
A recent study from Stanford Medicine has provided new insights into the safety of two.
Belly Fat vs BMI in Colorectal Cancer Risk
A recent study highlights that central obesity, specifically belly fat, is a stronger predictor of.
COVID-19 & Autoimmune Care Hope: Natural Proteins
Recent research at Umeå University reveals how natural proteins could revolutionize treatments for COVID-19, autoimmune.